Actively Recruiting

Age: 18Years - 100Years
All Genders
ID05424978

Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi'an

Led by Xi'an No.3 Hospital · Updated on 2024-01-26

3600

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to observe how the standardized green channel treatment system for acute ischemic stroke is applied in real-world clinical practice in Xi'an. The study collects clinical data from patients who received this treatment to evaluate their prognosis, including mortality, stroke recurrence, and complications like cerebral hemorrhage and pneumonia within 90 days after stroke onset. The standardized green channel treatment includes six key steps: prompt triage by nurses, rapid assessment by emergency doctors, immediate activation of the stroke green channel when stroke is suspected, and accompaniment by stroke doctors and nurses during CT examinations. Treatment options include intravenous thrombolysis and, depending on timing and vascular condition, intravascular intervention such as mechanical thrombolysis. Multi-mode imaging is used to evaluate patients whose stroke onset time exceeds six hours before deciding on endovascular treatment. Participants will be monitored for outcomes such as functional independence 90 days after stroke onset. During hospitalization, the rates of cerebral hemorrhage and pneumonia are tracked. Researchers collect data on mortality and stroke recurrence within 90 days. The study involves clinical evaluations, imaging, and follow-up assessments to understand the effectiveness and practical use of the green channel system for stroke care.

CONDITIONS

Brief Title

Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years old
  • Diagnosed with acute ischemic stroke
  • Stroke onset within 24 hours before enrollment
  • Provided informed consent to participate
Not Eligible

You will not qualify if you...

  • Refusal to receive intravenous thrombolysis or intravascular intervention
  • Stroke caused by brain tumor, brain trauma, or blood diseases
  • History of stroke with prior disability affecting outcome assessment (mRS 2 points before current stroke)
  • Presence of limb dysfunction from conditions like claudication, osteoarthritis, rheumatoid arthritis, or gout affecting neurological exam
  • Severe liver or kidney failure (ALT or AST over twice normal; creatinine over twice normal)
  • Serious life-threatening diseases with expected survival under 3 months
  • Other diseases limiting neurological function evaluation or follow-up
  • Women planning pregnancy or breastfeeding
  • Currently participating in other clinical trials
  • Refusal to participate in investigator registration

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) for eligibility assessment

Standardized Green Channel Treatment

Duration - During hospitalization

Participants receive rapid assessment and treatment for acute ischemic stroke through a standardized green channel system including triage, imaging, intravenous thrombolysis, and possible endovascular intervention depending on clinical findings and timing.

Multiple visits during hospitalization as part of treatment and monitoring

Follow-up Monitoring

Duration - Up to 90 days after onset

Participants are monitored for functional independence, mortality, stroke recurrence, and complications such as cerebral hemorrhage and pneumonia for up to 90 days after stroke onset.

Follow-up visits as scheduled up to 90 days after stroke onset

Trial Site Locations

Total: 1 location

1

Xi 'an No.3 Hospital

Xi'an, Shaanxi, China, 710018

Actively Recruiting

Loading map...

Research Team

M

Mingze Chang, Doctor

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Multicenter, Randomized, Double-blind, Placebo-controlled ...

Acute Ischemic Stroke

Actively Recruiting

1 location

A Multicenter, Randomized Controlled Clinical Investigation ...

Acute Ischemic Stroke

Actively Recruiting

1 location

A Prospective Multicenter Registry Study on BASIS Technique ...

Acute Ischemic Stroke

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here